Kéri G - Search Results

1

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Kelleher MT, Fruhwirth G, Patel G, Ofo E, Festy F, Barber PR, Ameer-Beg SM, Vojnovic B, Gillett C, Coolen A, Kéri G, Ellis PA, Ng T. Kelleher MT, et al. Among authors: keri g. Target Oncol. 2009 Sep;4(3):235-52. doi: 10.1007/s11523-009-0116-y. Epub 2009 Sep 16. Target Oncol. 2009. PMID: 19756916 Free PMC article. Review.

2

The challenges of integrating molecular imaging into the optimization of cancer therapy.

Patel GS, Kiuchi T, Lawler K, Ofo E, Fruhwirth GO, Kelleher M, Shamil E, Zhang R, Selvin PR, Santis G, Spicer J, Woodman N, Gillett CE, Barber PR, Vojnovic B, Kéri G, Schaeffter T, Goh V, O'Doherty MJ, Ellis PA, Ng T. Patel GS, et al. Among authors: keri g. Integr Biol (Camb). 2011 Jun;3(6):603-31. doi: 10.1039/c0ib00131g. Epub 2011 May 4. Integr Biol (Camb). 2011. PMID: 21541433 Review.

3

How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology.

Fruhwirth GO, Fernandes LP, Weitsman G, Patel G, Kelleher M, Lawler K, Brock A, Poland SP, Matthews DR, Kéri G, Barber PR, Vojnovic B, Ameer-Beg SM, Coolen AC, Fraternali F, Ng T. Fruhwirth GO, et al. Among authors: keri g. Chemphyschem. 2011 Feb 25;12(3):442-61. doi: 10.1002/cphc.201000866. Epub 2011 Feb 15. Chemphyschem. 2011. PMID: 21328516 Review.

4

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

Győrffy B, Bottai G, Lehmann-Che J, Kéri G, Orfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de Thè H, André F, Sotiriou C, Hortobagyi GN, Di Leo A, Pusztai L, Santarpia L. Győrffy B, et al. Among authors: keri g. Mol Oncol. 2014 May;8(3):508-19. doi: 10.1016/j.molonc.2013.12.018. Epub 2014 Jan 5. Mol Oncol. 2014. PMID: 24462521 Free PMC article.

5

Tyrosine kinase inhibitors - small molecular weight compounds inhibiting EGFR.

Hegymegi-Barakonyi B, Eros D, Szántai-Kis C, Breza N, Bánhegyi P, Szabó GV, Várkondi E, Peták I, Orfi L, Kéri G. Hegymegi-Barakonyi B, et al. Among authors: keri g. Curr Opin Mol Ther. 2009 Jun;11(3):308-21. Curr Opin Mol Ther. 2009. PMID: 19479664

6

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter.

Ozvegy-Laczka C, Hegedus T, Várady G, Ujhelly O, Schuetz JD, Váradi A, Kéri G, Orfi L, Német K, Sarkadi B. Ozvegy-Laczka C, et al. Among authors: keri g. Mol Pharmacol. 2004 Jun;65(6):1485-95. doi: 10.1124/mol.65.6.1485. Mol Pharmacol. 2004. PMID: 15155841

7

Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.

Torka R, Pénzes K, Gusenbauer S, Baumann C, Szabadkai I, Őrfi L, Kéri G, Ullrich A. Torka R, et al. Among authors: keri g. Neoplasia. 2014 Apr;16(4):301-18. doi: 10.1016/j.neo.2014.03.009. Neoplasia. 2014. PMID: 24862757 Free PMC article.

8

Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1.

Hegedus T, Orfi L, Seprodi A, Váradi A, Sarkadi B, Kéri G. Hegedus T, et al. Among authors: keri g. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):318-25. doi: 10.1016/s0925-4439(02)00095-9. Biochim Biophys Acta. 2002. PMID: 12084474 Free article. Review.

9

Identification of protein kinase inhibitors with a selective negative effect on the viability of Epstein-Barr virus infected B cell lines.

Mavromatidis V, Varga Z, Waczek F, Őrfi Z, Őrfi L, Kéri G, Mosialos G. Mavromatidis V, et al. Among authors: keri g. PLoS One. 2014 Apr 23;9(4):e95688. doi: 10.1371/journal.pone.0095688. eCollection 2014. PLoS One. 2014. PMID: 24759913 Free PMC article.

10

Comparison of the cytotoxic effects of receptor tyrosine kinase inhibitors on macrophage functions; possible side effects in the immune defense.

Hrabák A, Bökönyi G, Orfi L, Bajor T, Kéri G. Hrabák A, et al. Among authors: keri g. Immunol Lett. 2006 Nov 15;107(2):169-75. doi: 10.1016/j.imlet.2006.09.006. Epub 2006 Oct 18. Immunol Lett. 2006. PMID: 17098294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters